814P - Longer time from diagnosis to docetaxel treatment results in a shorter survival in metastatic hormonosensitive prostate cancer (mHSPC) patients treated with chemotherapy+androgen deprivation therapy (ADT)
| Autor: | Climent Duran, M.A., Mellado, B., Piulats Rodriguez, J.M., Heras Lopez, L., Juan, M.J., Sáez, M.I., Reig, O., Montesa, A., Suarez, J.F., Hajianfar, R., Ribal, M.J., Rubio, J., Castells, M., Villatoro, R., Sandiego, S., Olmos Hidalgo, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v282-v282 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|